H.R.4087 - Prescription Drug Labeling Promotion Act of 2012112th Congress (2011-2012)
|Sponsor:||Rep. Markey, Edward J. [D-MA-7] (Introduced 02/24/2012)|
|Committees:||House - Energy and Commerce|
|Latest Action:||02/24/2012 Referred to the House Committee on Energy and Commerce.|
|Notes:||For further action, see S.3187, which became Public Law 112-144 on 7/9/2012.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.4087 — 112th Congress (2011-2012)All Bill Information (Except Text)
Introduced in House (02/24/2012)
Prescription Drug Labeling Promotion Act of 2012 - Directs the Secretary of Health and Human Services (HHS) to establish a working group to develop best practices on access to prescription drug labeling for the visually impaired.
Requires the working group to: (1) include equal representation of consumer and industry advocates; (2) promulgate guidance on best practices for pharmacies to ensure that blind and visually impaired individuals have safe, consistent, reliable, and independent access to the information in the labeling of prescription drugs; (3) consider the use of Braille, specified auditory means, and enhanced visual means to provide such access; and (4) consider whether there are technical, financial, manpower, or other factors that may fundamentally impact the ability of pharmacies with 20 or fewer retail locations to implement the best practices.
Directs the Commissioner of Food and Drugs (FDA) to conduct an informational and educational program to inform the public and pharmacists about such guidance and practices.
Directs the Comptroller General: (1) 18 months after such guidance and practices are published, to review pharmacy compliance and the extent to which access barriers continue; and (2) by September 30, 2016, to report on such review, including recommendations for reducing such barriers.